Central cholinergic activation of a vagus nerve-to-spleen circuit alleviates experimental colitis

Mucosal Immunology

Volumn 7, Issue 2, 2014, Pages 335-347

  Ji, H ^a   Rabbi, M F ^a   Labis, B ^a   Pavlov, V A ^b   Tracey, K J ^b   Ghia, J E ^a,c  

^a UNIVERSITY OF MANITOBA   (Canada)

^b FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

^c MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BUNGAROTOXIN RECEPTOR; CYTOKINE; GALANTAMINE; GLYCOPROTEIN P 15095; HUPERZINE A; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; METHOCTRAMINE; [4 [(3 CHLOROPHENYL)CARBAMOYLOXY] 2 BUTYNYL]TRIMETHYLAMMONIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CHOLINERGIC STIMULATION; COLITIS; CONTROLLED STUDY; CYTOKINE RELEASE; DOSE RESPONSE; DRUG EFFICACY; MALE; MOUSE; NEURECTOMY; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SPLEEN; SPLEEN CELL; SPLENECTOMY; VAGOTOMY; VAGUS NERVE;

ALPHA7 NICOTINIC ACETYLCHOLINE RECEPTOR; ANIMALS; CHOLINESTERASE INHIBITORS; COLITIS; CYTOKINES; DISEASE MODELS, ANIMAL; GALANTAMINE; LIGANDS; MALE; MICE; RECEPTORS, MUSCARINIC; SEVERITY OF ILLNESS INDEX; SIGNAL TRANSDUCTION; SPLEEN; VAGUS NERVE;

EID: 84895144365     PISSN: 19330219     EISSN: 19353456     Source Type: Journal    
DOI: 10.1038/mi.2013.52     Document Type: Article

References (61)

1. Molodecky, N.A. et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology 142, 46-54. e42; quiz e30 (2012).
2. Strober, W. & Fuss, I.J. Proinflammatory cytokines in the pathogenesis of inflammatory bowel diseases. Gastroenterology 140, 1756-1767 (2011).
3. Perrier, C. & Rutgeerts, P. Cytokine blockade in inflammatory bowel diseases. Immunotherapy 3, 1341-1352 (2011).
4. Ghia, J.E., Blennerhassett, P., Kumar-Ondiveeran,H., Verdu, E.F. & Collins, S.M. The vagus nerve: A tonic inhibitory influence associated with inflammatory bowel disease in a murine model. Gastroenterology 131, 1122-1130 (2006).
5. Goldstein, R.S. et al. Cholinergic anti-inflammatory pathway activity and High Mobility Group Box-1 (HMGB1) serum levels in patients with rheumatoid arthritis. Mol. Med. 13, 210-215 (2007).
6. The, F. et al. Central activation of the cholinergic anti-inflammatory pathway reduces surgical inflammation in experimental post-operative ileus. Br. J. Pharmacol. 163, 1007-1016 (2011).
7. Borovikova, L.V. et al. Role of vagus nerve signaling in CNI-1493-mediated suppression of acute inflammation. Auton. Neurosci. 85, 141-147 (2000).
8. Van Der Zanden, E.P., Boeckxstaens, G.E. & de Jonge, W.J. The vagus nerve as a modulator of intestinal inflammation. Neurogastroenterol. Motil. 21, 6-17 (2009).
9. Pavlov, V.A. & Tracey, K.J. The vagus nerve and the inflammatory reflex-linking immunity and metabolism. Nat. Rev. Endocrinol. 8, 743-754 (2012).
10. Lindgren, S., Stewenius, J., Sjolund, K., Lilja, B. & Sundkvist, G. Autonomic vagal nerve dysfunction in patients with ulcerative colitis. Scand. J. Gastroenterol. 28, 638-642 (1993).
11. Meregnani, J. et al. Anti-inflammatory effect of vagus nerve stimulation in a rat model of inflammatory bowel disease. Auton. Neurosci. 160, 82-89 (2011).
12. Cosnes, J. Tobacco and IBD: Relevance in the understanding of disease mechanisms and clinical practice. Best Pract. Res.Clin. Gastroenterol. 18, 481-496 (2004).
13. Frolkis, A. et al. Environment and the inflammatory bowel diseases. Can. J. Gastroenterol. 27, e18-e24 (2013).
14. Drakes, M.L., Blanchard, T.G. & Czinn, S.J. Colon lamina propria dendritic cells induce a proinflammatory cytokine response in lamina propria T cells in the SCID mouse model of colitis. J. Leukoc. Biol. 78, 1291-1300 (2005).
15. Ikeda, Y., Ueno, A., Naraba, H. & Oh-ishi, S. Involvement of vanilloid receptor VR1 and prostanoids in the acid-induced writhing responses of mice. Life Sci. 69, 2911-2919 (2001).
16. te Velde, A.A. et al. Increased expression of DC-SIGN+IL-12+IL-18+ and CD83+IL-12-IL-18-dendritic cell populations in the colonic mucosa of patients with Crohn's disease. Eur. J. Immunol. 33, 143-151 (2003).
17. Berndt, B.E., Zhang, M.,Chen,G.H., Huffnagle, G.B.&Kao, J.Y. The role of dendritic cells in the development of acute dextran sulfate sodium colitis. J. Immunol. 179, 6255-6262 (2007).
18. Yoshikawa, H. et al. Nicotine inhibits the production of proinflammatory mediators in human monocytes by suppression of I-kappaB phosphorylation and nuclear factor-kappaB transcriptional activity through nicotinic acetylcholine receptor alpha7. Clin. Exp. Immunol. 146, 116-123 (2006).
19. Kawashima, K., Yoshikawa, K., Fujii, Y.X., Moriwaki, Y. & Misawa, H. Expression and function of genes encoding cholinergic components in murine immune cells. Life Sci. 80, 2314-2319 (2007).
20. Pavlov, V.A. et al. Central muscarinic cholinergic regulation of the systemic inflammatory response during endotoxemia. Proc. Natl. Acad. Sci. USA 103, 5219-5223 (2006).
21. Pavlov, V.A. et al. Brain acetylcholinesterase activity controls systemic cytokine levels through the cholinergic anti-inflammatory pathway. Brain Behav. Immun. 23, 41-45 (2009).
22. Ellis, J.M. Cholinesterase inhibitors in the treatment of dementia. J. Am. Osteopath. Assoc. 105, 145-158 (2005).
23. Waldburger, J.M. et al. Spinal p38 MAP kinase regulates peripheral cholinergic outflow. Arthritis Rheum. 58, 2919-2921 (2008).
24. Shifrin, H., Nadler-Milbauer,M., Shoham, S. & Weinstock, M. Rivastigmine alleviates experimentally induced colitis in mice and rats by acting at central and peripheral sites to modulate immune responses. PLoS One 8, e57668 (2013).
25. Rosas-Ballina, M. et al. Acetylcholine-synthesizing T cells relay neural signals in a vagus nerve circuit. Science 334, 98-101 (2011).
26. Bickel, U., Thomsen, T., Fischer, J.P., Weber, W. & Kewitz, H. Galanthamine: Pharmacokinetics, tissue distribution and cholinesterase inhibition in brain of mice. Neuropharmacology 30, 447-454 (1991).
27. Stillman, M.J., Shukitt-Hale, B., Kong, R.M., Levy, A. & Lieberman, H.R. Elevation of hippocampal extracellular acetylcholine levels by methoctramine. Brain Res. Bull. 32, 385-389 (1993).
28. Lachowicz, J.E. et al. Facilitation of acetylcholine release and improvement in cognition by a selective M2 muscarinic antagonist, SCH 72788. Life Sci. 68, 2585-2592 (2001).
29. Ghia, J.E., Blennerhassett, P. & Collins, S.M. Vagus nerve integrity and experimental colitis. Am. J. Physiol. Gastrointest. Liver Physiol. 293, G560-G567 (2007).
30. Texido, L. et al. Effect of galantamine on the human alpha7 neuronal nicotinic acetylcholine receptor, the Torpedo nicotinic acetylcholine receptor and spontaneous cholinergic synaptic activity. Br. J. Pharmacol. 145, 672-678 (2005).
31. Miceli, P.C. & Jacobson, K. Cholinergic pathways modulate experimental dinitrobenzene sulfonic acid colitis in rats. Auton. Neurosci. 105, 16-24 (2003).
32. Mazelin, L., Theodorou, V., More, J., Fioramonti, J. & Bueno, L. Protective role of vagal afferents in experimentally-induced colitis in rats. J. Auton. Nerv. Syst. 73, 38-45 (1998).
33. Van Westerloo, D.J. et al. The vagus nerve and nicotinic receptors modulate experimental pancreatitis severity in mice. Gastroenterology 130, 1822-1830 (2006).
34. Xue, N., Liang, H., Yao, H., Song, X.M. & Li, J.G. The role of spleen in vagus nerve stimulation for treatment against septic shock in rats. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue 23, 263-266 (2011).
35. Borovikova, L.V. et al. Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature 405, 458-462 (2000).
36. Karimi, K., Bienenstock, J., Wang, L. & Forsythe, P. The vagus nerve modulates CD4+ Tcell activity. Brain Behav. Immun. 24, 316-323 (2010).
37. Abe, K. et al. Conventional dendritic cells regulate the outcome of colonic inflammation independently of T cells. Proc. Natl. Acad. Sci. USA 104, 17022-17027 (2007).
38. Sanchez-Munoz, F., Dominguez-Lopez, A. & Yamamoto-Furusho, J.K. Role of cytokines in inflammatory bowel disease. World J. Gastroenterol. 14, 4280-4288 (2008).
39. Krieglstein, C.F. et al. Role of appendix and spleen in experimental colitis. J. Surg. Res. 101, 166-175 (2001).
40. Tracey, K.J. Understanding immunity requires more than immunology. Nat. Immunol. 11, 561-564 (2010).
41. Saeed, R.W. et al. Cholinergic stimulation blocks endothelial cell activation and leukocyte recruitment during inflammation. J. Exp. Med. 201, 1113-1123 (2005).
42. Guinet, E., Yoshida,K.&Nouri-Shirazi, M. Nicotinic environment affects the differentiation and functional maturation of monocytes derived dendritic cells (DCs). Immunol. Lett. 95, 45-55 (2004).
43. Nouri-Shirazi, M., Tinajero, R. & Guinet, E. Nicotine alters the biological activities of developing mouse bone marrow-derived dendritic cells (DCs). Immunol. Lett. 109, 155-164 (2007).
44. Jacobson, K., McHugh, K. & Collins, S.M. Experimental colitis alters myenteric nerve function at inflamed and noninflamed sites in the rat. Gastroenterology 109, 718-722 (1995).
45. McCafferty, D.M., Wallace, J.L. & Sharkey, K.A. Effects of chemical sympathectomy and sensory nerve ablation on experimental colitis in the rat. Am. J. Physiol. 272, G272-G280 (1997).
46. Antonica, A., Ayroldi, E., Magni, F. & Paolocci, N. Lymphocyte traffic changes induced by monolateral vagal denervation in mouse thymus and peripheral lymphoid organs. J. Neuroimmunol. 64, 115-122 (1996).
47. Gottwald, T.P., Lhotak, S. & Stead, R.H. Effects of subdiaphragmatic vagotomy on mucosal mast cell densities in stomach and jejunum of rats. Adv. Exp. Med. Biol. 371A, 303-306 (1995).
48. Dapoigny, M., Cowles, V.E., Zhu, Y.R. & Condon, R.E. Vagal influence on colonic motor activity in conscious nonhuman primates. Am. J. Physiol. 262, G231-G236 (1992).
49. Ghia, J.E., Blennerhassett, P. & Collins, S.M. Impaired parasympathetic function increases susceptibility to inflammatory bowel disease in a mouse model of depression. J. Clin. Invest. 118, 2209-2218 (2008).
50. Diamond, A., Kenney,C. & Jankovic, J. Effect of vagal nerve stimulation in a case of Tourette's syndrome and complex partial epilepsy. Mov. Disord. 21, 1273-1275 (2006).
51. Huang, S.T., Chen,G.Y., Lo,H.M., Lin, J.G., Lee, Y.S. &Kuo,C.D. Increase in the vagal modulation by acupuncture at neiguan point in the healthy subjects. Am. J. Chin. Med. 33, 157-164 (2005).
52. Sakai, S.,Hori, E., Umeno, K.,Kitabayashi, N.,Ono, T.&Nishijo,H. Specific acupuncture sensation correlates with EEGs and autonomic changes in human subjects. Auton. Neurosci. 133, 158-169 (2007).
53. Kubota, Y. et al. Frontal midline theta rhythm is correlated with cardiac autonomic activities during the performance of an attention demanding meditation procedure. Brain Res. Cogn. Brain Res. 11, 281-287 (2001).
54. Paul-Labrador, M et al. Effects of a randomized controlled trial of transcendental meditation on components of the metabolic syndrome in subjects with coronary heart disease. Arch. Intern. Med. 166, 1218-1224 (2006).
55. Ghia, J.E., Galeazzi, F., Ford, D.C., Hogaboam, C.M., Vallance, B.A. & Collins, S.M. Role ofM-CSF dependentmacrophages in colitis is driven by the nature of the inflammatory stimulus. Am. J. Physiol. Gastrointest. Liver Physiol. 294, 770-777 (2008).
56. Okayasu, I., Hatakeyama, S., Yamada, M., Ohkusa, T., Inagaki, Y. & Nakaya, R. A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology 98, 694-702 (1990).
57. Rosenwald, A., Reusche, E., Ogomori, K. & Teichert, H.M. Comparison of silver stainings and immunohistology for the detection of neurofibrillary tangles and extracellular cerebral amyloid in paraffin sections. Acta Neuropathol. (Berl) 86, 182-186 (1993).
58. Cooper, H.S., Murthy, S.N., Shah, R.S. & Sedergran, D.J. Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Lab. Invest. 69, 238-249 (1993).
59. Appleyard, C.B. &Wallace, J.L. Reactivation of hapten-induced colitis and its prevention by anti-inflammatory drugs. Am. J. Physiol. 269,G119-G125 (1995).
60. Boughton-Smith, N.K.,Wallace, J.L. &Whittle, B.J. Relationship between arachidonic acid metabolism, myeloperoxidase activity and leukocyte infiltration in a rat model of inflammatory bowel disease. Agents Actions 25, 115-123 (1988).
61. Zhang, L, Procuik, M, Fang, T & Kung, SK. Functional analysis of the quantitative expression of a costimulatory molecule on dendritic cells using lentiviral vector-mediated RNA interference. J. Immunol. Methods 344, 87-97 (2009).